COVID-19 Vaccines
Which COVID-19 vaccines have applied for emergency authorization in India?
2 min read
By Apollo 24/7, Published on- 09 December 2020, Updated on - 18 October 2022
Share this article
0
6 likes
What is emergency use authorization or approval?
Which vaccines have applied for emergency use in India?
- Pfizer’s COVID-19 vaccine candidate, developed in collaboration with BioNtech, and whose interim analysis of phase 3 trials revealed a 95% efficacy, has sought EUA from the Indian government.
- Serum Institute of India for ‘Covishield’, the vaccine being manufactured jointly with Oxford/AstraZeneca in India, has sought for EAU in India. Early analysis of phase 3 trials of the vaccine demonstrated a 70% efficacy.
- Bharat Biotech for ‘Covaxin’, India’s first indigenously developed COVID-19 vaccine, has applied for EUA. The National Institute of Virology-ICMR is collaborating with Bharat Biotech to develop this vaccine.
Who approves the emergency use of vaccines?
- United States – U.S Food and Drug Administration (FDA)
- Britain – Medicines and Healthcare products Regulatory Agency (MHRA)
- China – National Medical Products Administration
- Russia – European Medicines Agency (EMA)
How long does the approval process take?
Services
Buy Apollo Products
Online Consultations
Order Online Test
References+2
COVID-19 Vaccines
Leave Comment
Services
Buy Apollo Products
Online Consultations
Order Online Test
Recommended for you
COVID-19 Vaccines
COVID-19 Vaccines: How effective are they in the real world?
Recently, several scientific studies have been released highlighting the difference between the clinical efficacy of some of the top COVID-19 vaccines and their real-world effectiveness.
COVID-19 Vaccines
Anyone aged over 45 years can now get vaccinated for COVID-19
The Indian government recently announced that everyone aged 45 years and above would be eligible for COVID-19 vaccination in the country, starting from 1st April 2021.
COVID-19 Vaccines
COVID-19 Vaccine: Opportunities and Challenges for India
India will play a strategic and central role in the global supply and distribution of various possible COVID-19 shots. However, the country will also likely face immense logistical challenges.
Subscribe
Sign up for our free Health Library Daily Newsletter
Get doctor-approved health tips, news, and more.
Visual Stories
COVID-19 Vaccine Factbox: Sputnik V
Tap to continue exploring
Recommended for you
COVID-19 Vaccines
COVID-19 Vaccines: How effective are they in the real world?
Recently, several scientific studies have been released highlighting the difference between the clinical efficacy of some of the top COVID-19 vaccines and their real-world effectiveness.
COVID-19 Vaccines
Anyone aged over 45 years can now get vaccinated for COVID-19
The Indian government recently announced that everyone aged 45 years and above would be eligible for COVID-19 vaccination in the country, starting from 1st April 2021.
COVID-19 Vaccines
COVID-19 Vaccine: Opportunities and Challenges for India
India will play a strategic and central role in the global supply and distribution of various possible COVID-19 shots. However, the country will also likely face immense logistical challenges.